The PTPN2/N1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity [PTPN2i-MS-TCRseq]

ABSTRACT: To assess TCR diversity in AC484-treated tumors we profiled the TCRβ chain repertoire from untreated, anti-PD-1-treated, or AC484-treated B16 tumours

ORGANISM(S): Mus musculus

PROVIDER: GSE237374 | GEO | 2023/07/14

REPOSITORIES: GEO